Prognostic Factors for Patient with Carcinoma of Unknown Primary Site

Purpose: To evaluate a patient with a carcinoma of unknown primary site using the prognostic factors reported by Seve et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with a cancer of unknown primary site?

Yes

Does the patient have liver metastases?

Yes

Serum LDH in IU/L

Upper limit of the normal reference range for serum LDH

Serum albumin in g/dL

Lower limit of the normal reference range for albumin

White blood cell count per µL

Percent lymphocytes in the differential count (enter from 0 to 100)

Select an appropriate answer for each finding

Comorbidity

Performance status

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of adverse prognostic factors

Risk group based on serum albumin and liver metastases

Expected median survival

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
- Evaluation of Cancer Patient with Headache for Intracranial Metastases
- PROMISE Model for Patient with Malignant Pleural Effusion
Imaging Studies
- Peritoneal Cancer Index (PCI) for Quantitation of Abdominal and Pelvic Metastases on CT Scan
Laboratory Tests
- Biochemical PROMISE Score for Patient with Malignant Pleural Effusion
Criteria For Diagnosis
- Score Index for Radiosurgery (SIR) for Patient with Brain Metastases
Severity, Prognosis, Stage

Therapy

Options
- Score Index for Radiosurgery (SIR) for Patient with Brain Metastases
- Diagnosis of Metastatic Breast Cancer to Bone
Selection
- Diagnosis of Metastatic Breast Cancer to Bone

Monitoring

Response To Therapy
- Score Index for Radiosurgery (SIR) for Patient with Brain Metastases
Disease Progression
- Score Index for Radiosurgery (SIR) for Patient with Brain Metastases

Specialty

Hematology Oncology
Surgery, general

Objective

risk factors
selection

ICD-10

C80.9 - Malignant neoplasm, primary site unspecified

Info

Purpose: To evaluate a patient with a carcinoma of unknown primary site using the prognostic factors reported by Seve et al.

Specialty: Hematology Oncology, Surgery, general

Objective: risk factors, selection

ICD-10: C80.9,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path